Fused imidazole derivatives used as IL-17 inhibitors
MA51610AUndetermined Publication Date: 2021-04-21UCB BIOPHARMA SPRL
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA51610
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2018-12-11
- Filing Date
- 2019-01-10
- Publication Date
- 2021-04-21
Need to check novelty before this filing date? Find Prior Art
No text content released.